631 related articles for article (PubMed ID: 17049391)
1. Treatment practices in heart failure with preserved left ventricular ejection fraction: a prospective observational study.
Peltier M; Houpe D; Cohen-Solal A; Béguin M; Levy F; Tribouilloy C
Int J Cardiol; 2007 Jun; 118(3):363-9. PubMed ID: 17049391
[TBL] [Abstract][Full Text] [Related]
2. Heart failure due to left ventricular systolic dysfunction: treatment at discharge from hospital and at one year.
Houpe D; Peltier M; Cohen-Solal A; Béguin M; Lévy F; Slama M; Chapelain K; Tribouilloy C
Int J Cardiol; 2005 Sep; 103(3):286-92. PubMed ID: 16098391
[TBL] [Abstract][Full Text] [Related]
3. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
[TBL] [Abstract][Full Text] [Related]
4. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
Aronow WS
J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
[TBL] [Abstract][Full Text] [Related]
5. National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction.
Masoudi FA; Rathore SS; Wang Y; Havranek EP; Curtis JP; Foody JM; Krumholz HM
Circulation; 2004 Aug; 110(6):724-31. PubMed ID: 15289383
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction.
Badano LP; Albanese MC; De Biaggio P; Rozbowsky P; Miani D; Fresco C; Fioretti PM
J Am Soc Echocardiogr; 2004 Mar; 17(3):253-61. PubMed ID: 14981424
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and prognosis associated with a preserved left ventricular systolic function in a large cohort of congestive heart failure outpatients managed by cardiologists. Data from the Italian Network on Congestive Heart Failure.
Tarantini L; Faggiano P; Senni M; Lucci D; Bertoli D; Porcu M; Opasich C; Tavazzi L; Maggioni AP
Ital Heart J; 2002 Nov; 3(11):656-64. PubMed ID: 12506524
[TBL] [Abstract][Full Text] [Related]
8. Predictors of mortality in younger and older patients with heart failure and preserved or reduced left ventricular ejection fraction.
Kerzner R; Gage BF; Freedland KE; Rich MW
Am Heart J; 2003 Aug; 146(2):286-90. PubMed ID: 12891197
[TBL] [Abstract][Full Text] [Related]
9. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome.
Gotsman I; Rubonivich S; Azaz-Livshits T
Isr Med Assoc J; 2008 Mar; 10(3):214-8. PubMed ID: 18494235
[TBL] [Abstract][Full Text] [Related]
10. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.
Shah R; Wang Y; Foody JM
Am J Cardiol; 2008 Jan; 101(2):217-22. PubMed ID: 18178410
[TBL] [Abstract][Full Text] [Related]
11. Association of blood pressure and its evolving changes with the survival of patients with heart failure.
Grigorian-Shamagian L; Gonzalez-JuAnatey JR; Vazquez R; Cinca J; Bayes-Genis A; Pascual D; Fernandez-Palomeque C; Bardaji A; Almendral J; Nieto V; Macaya C; Jimenez RP; de Luna AB;
J Card Fail; 2008 Sep; 14(7):561-8. PubMed ID: 18722321
[TBL] [Abstract][Full Text] [Related]
12. [Comparative study on characteristics of congestive heart failure patients with preserved versus abnormal left ventricular systolic function and evaluation effects of therapy].
Zhan H; Tse HF; Cao JM; Lau CP
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Apr; 18(4):210-5. PubMed ID: 16647010
[TBL] [Abstract][Full Text] [Related]
13. Value of medical therapy in patients >80 years of age with heart failure and preserved ejection fraction.
Tehrani F; Phan A; Chien CV; Morrissey RP; Rafique AM; Schwarz ER
Am J Cardiol; 2009 Mar; 103(6):829-33. PubMed ID: 19268740
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of diabetes mellitus in patients with heart failure and preserved ejection fraction: a prospective five-year study.
Tribouilloy C; Rusinaru D; Mahjoub H; Tartière JM; Kesri-Tartière L; Godard S; Peltier M
Heart; 2008 Nov; 94(11):1450-5. PubMed ID: 18208832
[TBL] [Abstract][Full Text] [Related]
15. Impact of medical treatment on lung diffusion capacity in elderly patients with heart failure. Baseline characteristics and 1-year follow up after medical treatment.
Petersen CL; Kjaer A
Int J Cardiol; 2005 Feb; 98(3):453-7. PubMed ID: 15708179
[TBL] [Abstract][Full Text] [Related]
16. Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation.
Nieuwlaat R; Eurlings LW; Cleland JG; Cobbe SM; Vardas PE; Capucci A; López-Sendòn JL; Meeder JG; Pinto YM; Crijns HJ
J Am Coll Cardiol; 2009 May; 53(18):1690-8. PubMed ID: 19406345
[TBL] [Abstract][Full Text] [Related]
17. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.
Fonarow GC; Stough WG; Abraham WT; Albert NM; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
J Am Coll Cardiol; 2007 Aug; 50(8):768-77. PubMed ID: 17707182
[TBL] [Abstract][Full Text] [Related]
18. [Differences in clinical profile and outcome in patients with decompensated heart failure and systolic dysfunction or preserved systolic function].
Macín SM; Perna ER; Címbaro Canella JP; Alvarenga P; Pantich R; Ríos N; Farías EF; Badaracco JR
Rev Esp Cardiol; 2004 Jan; 57(1):45-52. PubMed ID: 14746717
[TBL] [Abstract][Full Text] [Related]
19. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
20. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
Fabbri G; Gorini M; Maggioni AP; Di Lenarda A;
G Ital Cardiol (Rome); 2007 Feb; 8(2):102-6. PubMed ID: 17402354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
